We are live on ! Find out more
GCM

Greywolf Capital Management Portfolio holdings

AUM $67.3M
1-Year Est. Return 100.05%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+100.05%
3 Year Est. Return
+174.41%
5 Year Est. Return
+148.91%
10 Year Est. Return
–
AUM
$372M
AUM Growth
-$192M
Cap. Flow
+$37.9M
Cap. Flow %
10.17%
Top 10 Hldgs %
99.4%
Holding
11
New
2
Increased
2
Reduced
2
Closed
–
Avg Time Held Equity + Options
4.2 quarters
Top 10 Avg Time Held Equity + Options
4.3 quarters
Top 20 Avg Time Held Equity + Options
4.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
4.2 quarters
Top 20 Avg Time Held Equity only
4.3 quarters

Top Sells

Rank Stock Value
1
AMAG
AMAG Pharmaceuticals
AMAG
+$20.6M

Sector Composition

Rank Sector Weight
1 Industrials 30.32%
2 Healthcare 27.35%
3 Miscellaneous 19%
4 Communication Services 15.04%
5 Materials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NPO icon
1
Enpro
NPO
$6.59B
$97.2M 26.1%
1,473,560
– –
2013 Q2
7 quarters
HMHC
2
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$56M 15.04%
+2,385,000
New +$49.1M
2015 Q1
0 quarters
ZINC
3
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
$45.9M 12.33%
3,625,300
+225,000
+7% +$3.06M
2014 Q2
3 quarters
MNKD icon
4
MannKind Corp
MNKD
$1.06B
$39.3M 10.56%
1,512,400
+71,086
+5% +$2.14M
2013 Q2
7 quarters
TARO
5
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$39.2M 10.53%
277,936
– –
2013 Q2
7 quarters
RBY
6
DELISTED
RUBICON MENERALS CORP (F)
RBY
$26.6M 7.15%
29,316,542
– –
2013 Q2
7 quarters
AMAG
7
DELISTED
AMAG Pharmaceuticals
AMAG
$23.3M 6.26%
431,552
-431,553
-50% -$20.6M
2014 Q4
1 quarter
SPY icon
8
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$833B
$22.6M 6.07%
1,095,000
-135,000
-11% -$27.9M
2013 Q4
5 quarters
LXFR icon
9
Luxfer Holdings
LXFR
$465M
$15.7M 4.22%
1,173,815
– –
2013 Q2
7 quarters
CMBT
10
CMB.TECH NV
CMBT
$5.98B
$4.22M 1.13%
+350,000
New +$4.16M
2015 Q1
0 quarters
WLT
11
CALL
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
$2.23M 0.6%
3,600,000
– –
2014 Q3
2 quarters

Similar funds

Greywolf Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Greywolf Capital Management held 11 positions worth $372M, down 34% from $565M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Greywolf Capital Management deployed $37.9M of net new capital in Q1 2015, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Houghton Mifflin Harcourt Company: 2,385,000 shares worth $56M.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 19% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was AMAG Pharmaceuticals, an estimated $20.6M trimmed.

  • Greywolf Capital Management's largest Q1 2015 buy was Houghton Mifflin Harcourt Company: 2,385,000 shares worth $56M.
  • Greywolf Capital Management added most to HORSEHEAD HLDG CORP COM STK (DE) in Q1 2015, an estimated $3.06M increase.
  • Greywolf Capital Management's biggest Q1 2015 reduction was AMAG Pharmaceuticals, cutting an estimated $20.6M.
  • Greywolf Capital Management's ten largest holdings make up 99% of its $372M portfolio in Q1 2015.
  • Greywolf Capital Management opened 2 new positions and closed 0 in Q1 2015.
  • Greywolf Capital Management's portfolio value fell 34% quarter-over-quarter to $372M.

Based on Greywolf Capital Management's 13F filing for Q1 2015, filed 15 May 2015.